Advertisement

Topics

Active Motif Company Profile

15:58 EST 15th December 2018 | BioPortfolio

As the sequencing of the human and other genomes is completed, researchers are focusing their efforts on determining the functions, interactions and regulation of the encoded proteins. Active Motif is dedicated to developing and delivering cell and molecular biology-based research tools along with the biocomputing resources that assist in the endeavor. It applies a multi-disciplinary approach to create new and modify existing technologies to meet the current and future needs of life science researchers. Active Motif intends for its products to help discover, decipher and understand the complexity of cellular function.

Location

1914 Palomar Oaks Way, Suite 150
Carlsbad
California
92008
United States of America

Contact

Phone: 760 431 1263
Fax: 760 431 1351
Email: sales@activemotif.com


News Articles [237 Associated News Articles listed on BioPortfolio]

Motif Bio waiting on FDA approval of iclaprim after “tremendous” first half

A decision on whether or not Motif can start marketing its next-generation antibiotic in the US is due by mid-February

US FDA accepts the NDA for Motif Bio’s iclaprim for ABSSSI treatment

The US Food & Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) by Motif Bio...Read More... The post US FDA accepts the NDA for Motif Bio’s iclaprim for ABSSSI ...

US FDA accepts the NDA for Motif Bio’s iclaprim for ABSSSI treatment

The US Food & Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) by Motif Bio...Read More... The post US FDA accepts the NDA for Motif Bio’s iclaprim for ABSSSI ...

Motif Bio secures new patents around optimal dose for iclaprim out to 2037

Graham Lumsden, chief executive of Motif Bio Plc (LON:MTFB, NASDAQ:MTFB) discusses with Proactive Investors the granting of two US patents which pushes their exclusivity over the antibiotic iclaprim...

Motif Bio files application with FDA for ABSSSI antibiotic

A marketing application was filed with the FDA by Motif Bio for its infectious disease product- and fast track-tagged Gram-po -More- 

FDA accepts Motif's antibiotic, grants priority review status

UK biopharma Motif Bio's marketing application for iclaprim, developed to treat acute bacterial skin and skin structure infec -More- 

Motif Bio announces US FDA approval deadline for its antibiotic drug

Motif Bio (LON:MTFB, NASDAQ: MTFB) CEO Graham Lumsden tells Proactive Investors the US FDA has begun the process of assessing whether the company’s next-generation antibiotic should be allowed to ...

Motif Bio to present iclaprim data at microbiology conference in Portugal next month

Chief medical officer David Huang will give a presentation on Motif’s next generation antibiotic on September 5 at the conference, which is being held in Lisbon

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Epivir [GlaxoSmithKline LLC]

EPIVIR-HBV (lamivudine)Tablets EPIVIR-HBV (lamivudine)Oral Solution

PubMed Articles [990 Associated PubMed Articles listed on BioPortfolio]

Deiodinases share an evolutionarily conserved thyroid hormone-binding motif.

Human and animal thyroid hormone (TH) plasma carriers (THPC, n=426), cell surface TH transporters (CSTT, n=8,691), and TH nuclear receptors (TR, n=624) share a 49-position long TH-binding motif. Parti...

A novel mode of Capping Protein-regulation by Twinfilin.

Cellular actin assembly is controlled at the barbed ends of actin filaments, where capping protein (CP) limits polymerization. Twinfilin is a conserved in vivo binding partner of CP, yet the significa...

Crystal structure of human anterior gradient protein 3.

Oxidative protein folding in the endoplasmic reticulum is catalyzed by the protein disulfide isomerase family of proteins. Of the 20 recognized human family members, the structures of eight have been ...

Ceramide-transfer protein-mediated ceramide transfer is a structurally tunable flow-inducing mechanism with structural feed-forward loops.

This paper considers two models of ceramide-transfer protein (CERT)-mediated ceramide transfer at the -Golgi network proposed in the literature, and , and seeks (parameter-free) features of the two ...

A monovalent ion in the DNA binding interface of the eukaryotic junction-resolving enzyme GEN1.

GEN1 is a member of the FEN/EXO family of structure-selective nucleases that cleave 1 nt 3' to a variety of branchpoints. For each, the H2TH motif binds a monovalent ion and plays an important role in...

Clinical Trials [2516 Associated Clinical Trials listed on BioPortfolio]

The Effect of Selected Fibres and Flours in Flat Bread on Post-prandial Blood Glucose Responses

Identify one or more flat bread mixes that produce a reduction in positive incremental area under the curve (iAUC) of post-prandial glucose relative to the control product.

Efferocytosis and Genomic Polymorphism in Autoimmune Diseases

Over the past few years, growing evidences revealed that clearance of apoptotic cells by phagocytosis can result in powerful anti-inflammatory and immunosuppressive effects. In vivo, apopt...

HuMax-CD20 in Active Rheumatoid Arthritis

The purpose of this study is to evaluate the safety and effectiveness of HuMax-CD20 in patients with active Rheumatoid Arthritis.

Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)

This study is designed to test whether SCN5A mRNA processing is altered in OSA patients, which may contribute to their increased arrhythmic risk, and whether processing of SCN5A mRNA is mo...

Phototherapy Applied in Combination With Aerobic Training

Interventional

Companies [819 Associated Companies listed on BioPortfolio]

Active Motif

As the sequencing of the human and other genomes is completed, researchers are focusing their efforts on determining the functions, interactions and regulation of the encoded proteins. Active Motif is...

Active Motif, Inc.

Nil

Active.com

Active.com, a media property of The Active Network, Inc., is the leading online community for people who want to discover, learn about, share, register for and ultimately ...

Active Implants, LLC

Active Implants, LLC develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, allowing patients to maintain or return to an ac...

Active Implants Corporation

Active Implants LLC develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, allowing patients to maintain or return to an act...

More Information about "Active Motif" on BioPortfolio

We have published hundreds of Active Motif news stories on BioPortfolio along with dozens of Active Motif Clinical Trials and PubMed Articles about Active Motif for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Active Motif Companies in our database. You can also find out about relevant Active Motif Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record